Literature DB >> 19190518

Chronic obstructive lung diseases and risk of non-small cell lung cancer in women.

Ann G Schwartz1, Michele L Cote, Angela S Wenzlaff, Alison Van Dyke, Wei Chen, John C Ruckdeschel, Shirish Gadgeel, Ayman O Soubani.   

Abstract

INTRODUCTION: The link between lung cancer and chronic obstructive lung diseases (COPD) has not been well studied in women even though lung cancer and COPD account for significant and growing morbidity and mortality among women.
METHODS: We evaluated the relationship between COPD and non-small cell lung cancer in a population-based case-control study of women and constructed a time course of chronic lung diseases in relation to onset of lung cancer. Five hundred sixty-two women aged 18 to 74, diagnosed with non-small cell lung cancer and 564 population-based controls matched on race and age participated. Multivariable unconditional logistic regression models were used to estimate risk associated with a history of COPD, chronic bronchitis, or emphysema.
RESULTS: Lung cancer risk increased significantly for white women with a history of COPD (odds ratios [OR] = 1.85; 95% confidence intervals [CI]: 1.21-2.81), but this was not seen in African American women. Risk associated with a history of chronic bronchitis was strongest when diagnosed at age 25 or earlier (OR = 2.35, 95% CI: 1.17-4.72); emphysema diagnosed within 9 years of lung cancer was also associated with substantial risk (OR = 6.36, 95% CI: 2.36-17.13). Race, pack-years of smoking, exposure to environmental tobacco smoke as an adult, childhood asthma, and exposure to asbestos were associated with a history of COPD among lung cancer cases.
CONCLUSIONS: In women, COPD is associated with risk of lung cancer differentially by race. Untangling whether COPD is in the causal pathway or simply shares risk factors will require future studies to focus on specific COPD features, while exploring underlying genetic susceptibility to these diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19190518      PMCID: PMC2745706          DOI: 10.1097/JTO.0b013e3181951cd1

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  30 in total

Review 1.  COPD: racial disparities in susceptibility, treatment, and outcomes.

Authors:  Mark T Dransfield; William C Bailey
Journal:  Clin Chest Med       Date:  2006-09       Impact factor: 2.878

2.  Familial cancer history and lung cancer risk in United States nonsmoking men and women.

Authors:  S T Mayne; J Buenconsejo; D T Janerich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-12       Impact factor: 4.254

3.  What are the odds that smoking will kill you?

Authors:  M E Mattson; E S Pollack; J W Cullen
Journal:  Am J Public Health       Date:  1987-04       Impact factor: 9.308

4.  Personal and family history of lung disease as risk factors for adenocarcinoma of the lung.

Authors:  A H Wu; M C Yu; D C Thomas; M C Pike; B E Henderson
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

5.  A common familial component in lung cancer and chronic obstructive pulmonary disease.

Authors:  B H Cohen; E L Diamond; C G Graves; P Kreiss; D A Levy; H A Menkes; S Permutt; S Quaskey; M S Tockman
Journal:  Lancet       Date:  1977-09-10       Impact factor: 79.321

6.  Prior lung disease and risk of lung cancer in a large prospective study.

Authors:  Alyson J Littman; Mark D Thornquist; Emily White; Lisa A Jackson; Gary E Goodman; Thomas L Vaughan
Journal:  Cancer Causes Control       Date:  2004-10       Impact factor: 2.506

7.  Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up.

Authors:  David M Mannino; Samuel M Aguayo; Thomas L Petty; Stephen C Redd
Journal:  Arch Intern Med       Date:  2003-06-23

8.  Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States.

Authors:  A H Wu; E T Fontham; P Reynolds; R S Greenberg; P Buffler; J Liff; P Boyd; B E Henderson; P Correa
Journal:  Am J Epidemiol       Date:  1995-06-01       Impact factor: 4.897

Review 9.  Chronic obstructive pulmonary disease: molecular and cellular mechanisms.

Authors:  P J Barnes; S D Shapiro; R A Pauwels
Journal:  Eur Respir J       Date:  2003-10       Impact factor: 16.671

10.  Chronic obstructive pulmonary disease surveillance--United States, 1971-2000.

Authors:  David M Mannino; David M Homa; Lara J Akinbami; Earl S Ford; Stephen C Redd
Journal:  MMWR Surveill Summ       Date:  2002-08-02
View more
  26 in total

1.  Admixture mapping of lung cancer in 1812 African-Americans.

Authors:  Ann G Schwartz; Angela S Wenzlaff; Cathryn H Bock; Julie J Ruterbusch; Wei Chen; Michele L Cote; Amanda S Artis; Alison L Van Dyke; Susan J Land; Curtis C Harris; Sharon R Pine; Margaret R Spitz; Christopher I Amos; Albert M Levin; Paul M McKeigue
Journal:  Carcinogenesis       Date:  2010-11-29       Impact factor: 4.944

2.  The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence.

Authors:  Marileila Varella-Garcia; Aline P Schulte; Holly J Wolf; William J Feser; Chan Zeng; Sarah Braudrick; Xiang Yin; Fred R Hirsch; Timothy C Kennedy; Robert L Keith; Anna E Barón; Steven A Belinsky; York E Miller; Tim Byers; Wilbur A Franklin
Journal:  Cancer Prev Res (Phila)       Date:  2010-03-23

3.  Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.

Authors:  William J McCarthy; Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

4.  Retinoic acid-related orphan receptor-α is induced in the setting of DNA damage and promotes pulmonary emphysema.

Authors:  Ying Shi; Jiaofei Cao; Jane Gao; Liang Zheng; Andrew Goodwin; Chang Hyoek An; Avignat Patel; Janet S Lee; Steven R Duncan; Naftali Kaminski; Kusum V Pandit; Ivan O Rosas; Augustine M K Choi; Danielle Morse
Journal:  Am J Respir Crit Care Med       Date:  2012-06-28       Impact factor: 21.405

5.  The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.

Authors:  Nader Mina; Ayman O Soubani; Michele L Cote; Tariq Suwan; Angie S Wenzlaff; Sunil Jhajhria; Husam Samarah; Ann G Schwartz
Journal:  Clin Lung Cancer       Date:  2011-11-29       Impact factor: 4.785

6.  Circulating markers of interstitial lung disease and subsequent risk of lung cancer.

Authors:  Meredith S Shiels; Anil K Chaturvedi; Hormuzd A Katki; Bernadette R Gochuico; Neil E Caporaso; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-09       Impact factor: 4.254

7.  Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium.

Authors:  Albert Rosenberger; Heike Bickeböller; Valerie McCormack; Darren R Brenner; Eric J Duell; Anne Tjønneland; Soren Friis; Joshua E Muscat; Ping Yang; H-Erich Wichmann; Joachim Heinrich; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; David Zaridze; Peter Rudnai; Eleonora Fabianova; Vladimir Janout; Vladimir Bencko; Paul Brennan; Dana Mates; Ann G Schwartz; Michele L Cote; Zuo-Feng Zhang; Hal Morgenstern; Sam S Oh; John K Field; Olaide Raji; John R McLaughlin; John Wiencke; Loic LeMarchand; Monica Neri; Stefano Bonassi; Angeline S Andrew; Qing Lan; Wei Hu; Irene Orlow; Bernard J Park; Paolo Boffetta; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2011-12-22       Impact factor: 4.944

8.  Genetic epidemiology of cigarette smoke-induced lung disease.

Authors:  Ann G Schwartz
Journal:  Proc Am Thorac Soc       Date:  2012-05

9.  Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

Authors:  Michelle K McHugh; Matthew B Schabath; Chung-Han Ho; Mei Liu; Anthony M D'Amelio; Anthony J Greisinger; George L Delclos; Margaret R Spitz; Carol J Etzel
Journal:  J Immigr Minor Health       Date:  2013-10

10.  Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Darren R Brenner; Paolo Boffetta; Eric J Duell; Heike Bickeböller; Albert Rosenberger; Valerie McCormack; Joshua E Muscat; Ping Yang; H-Erich Wichmann; Irene Brueske-Hohlfeld; Ann G Schwartz; Michele L Cote; Anne Tjønneland; Søren Friis; Loic Le Marchand; Zuo-Feng Zhang; Hal Morgenstern; Neonila Szeszenia-Dabrowska; Jolanta Lissowska; David Zaridze; Peter Rudnai; Eleonora Fabianova; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Miriam Schejbalova; Paul Brennan; Ioan N Mates; Philip Lazarus; John K Field; Olaide Raji; John R McLaughlin; Geoffrey Liu; John Wiencke; Monica Neri; Donatella Ugolini; Angeline S Andrew; Qing Lan; Wei Hu; Irene Orlow; Bernard J Park; Rayjean J Hung
Journal:  Am J Epidemiol       Date:  2012-09-17       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.